Product Recalls in North Carolina

Product recalls affecting North Carolina — including food, drugs, consumer products, medical devices, and vehicles distributed to North Carolina. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 1,128 recalls have been distributed to North Carolina in the last 12 months.

54,363 total recalls
1,128 in last 12 months

Showing 2441–2460 of 13,606 recalls

DrugOctober 18, 2022· Genentech Inc

Recalled Item: Susvimo (ranibizumab injection) Recalled by Genentech Inc Due to Defective...

The Issue: Defective Delivery System: Commercial implants do not meet the filed...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 18, 2022· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg Recalled by SUN...

The Issue: Presence of Foreign Substance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Proparacaine Hydrochloride Ophthalmic Solution Recalled by Akorn, Inc. Due...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Ciprofloxacin Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Moxifloxacin Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP Deviations:

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Artificial Tears Solution Recalled by Akorn, Inc. Due to CGMP Deviations:

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Olopatadine HCl Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Timolol Maleate Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Cromolyn Sodium Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: ERYTHROMYCIN OPHTHALMIC OINTMENT USP 0.5% Recalled by Akorn, Inc. Due to...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Olopatadine HCl Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Artificial Tears OINTMENT Recalled by Akorn, Inc. Due to CGMP Deviations:

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: PAREMYD (hydroxyamphetamine hydrobromide/ tropicamide ophthalmic solution)...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Neomycin and Polymyxin B Sulfates Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Proparacaine Hydrochloride Ophthalmic Solution Recalled by Akorn, Inc. Due...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Olopatadine HCL Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Betaxolol Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP Deviations:

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Erythromycin Ophthalmic Ointment USP Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Olopatadine HCl Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 13, 2022· Akorn, Inc.

Recalled Item: Sodium Chloride Ophthalmic Ointment Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund